Related Experiment Video
Updated: Jun 20, 2026

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
Inhibition of Candida albicans biofilm formation by antimycotics released from modified polydimethyl siloxane
Kristof De Prijck1, Nele De Smet, Kris Honraet
1Laboratory of Pharmaceutical Microbiology, Ghent University, Harelbekestraat 72, Ghent, 9000, Belgium.
Abstract:
Unlike various disinfectants, antifungals have not been commonly incorporated so far in medical devices, such as catheters or prostheses, to prevent biofilm formation by Candida spp. In the present study, five antimycotics were added to polydimethyl siloxane (PDMS) disks via admixture (nystatin) or impregnation (trimethylsilyl-nystatin (TMS-nystatin), miconazole, tea tree oil (TTO), zinc pyrithione). Nystatin-medicated PDMS disks exhibited a concentration-dependent inhibitory effect on biofilm formation in a microtiter plate (MTP) but not in a Modified Robbins Device (MRD). This observation, together with HPLC data and agar diffusion tests, indicates that a small fraction of free nystatin is released, which kills Candida albicans cells in the limited volume of a MTP well. In contrast, biofilm inhibition amounted to more than one log unit in the MRD on disks impregnated with miconazole, TTO, and zinc pyrithione. It is hypothesized that the reduction in biofilm formation by these compounds in a flow system occurs through a contact-dependent effect.
Insights
Antifungal medical devices are not common. Miconazole, TTO, and zinc pyrithione effectively inhibited Candida spp. biofilm formation on PDMS disks in a flow system, suggesting a contact-dependent mechanism for preventing medical device infections.
Area of Science:
- Biomaterials Science
- Medical Mycology
- Infectious Diseases
Background:
- Antifungals are underutilized in medical devices compared to disinfectants for preventing Candida spp. biofilms.
- Candida spp. biofilm formation on medical devices like catheters and prostheses poses a significant clinical challenge.
- Polydimethyl siloxane (PDMS) is a common material for medical devices.
Purpose of the Study:
- To evaluate the efficacy of five antimycotics incorporated into PDMS disks for preventing Candida spp. biofilm formation.
- To compare the performance of different incorporation methods (admixture vs. impregnation).
- To investigate the mechanism of biofilm inhibition in different experimental setups.
Main Methods:
- Incorporation of nystatin (admixture), trimethylsilyl-nystatin, miconazole, tea tree oil (TTO), and zinc pyrithione into PDMS disks.
- Biofilm formation assays using microtiter plates (MTP) and a Modified Robbins Device (MRD).
- High-Performance Liquid Chromatography (HPLC) and agar diffusion tests to assess drug release and activity.
Main Results:
- Nystatin-medicated PDMS showed concentration-dependent biofilm inhibition in MTP but not MRD, indicating limited release.
- Miconazole, TTO, and zinc pyrithione-impregnated PDMS disks achieved >1 log unit biofilm inhibition in the MRD.
- Evidence suggests a contact-dependent mechanism for biofilm inhibition by miconazole, TTO, and zinc pyrithione in flow systems.
Conclusions:
- Miconazole, TTO, and zinc pyrithione are promising candidates for antifungal medical device coatings.
- Contact-dependent mechanisms are crucial for effective biofilm prevention in flow conditions.
- Further research is needed to optimize antifungal incorporation for sustained efficacy in vivo.
More Related Videos
Related Concept Videos
Antifungal Agents
Candidiasis
Biofilms

